Soros Fund Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-205,750
Closed -$18.3M 345
2017
Q1
$18.3M Buy
205,750
+50,250
+32% +$4.13M 0.37% 54
2016
Q4
$11M Sell
155,500
-9,700
-6% -$723K 0.25% 69
2016
Q3
$13.1M Sell
165,200
-14,800
-8% -$1.26M 0.33% 56
2016
Q2
$16.3M Hold
180,000
0.35% 50
2016
Q1
$15.3M Buy
180,000
+50,000
+38% +$3.72M 0.34% 67
2015
Q4
$10.3M Hold
130,000
0.17% 102
2015
Q3
$9.15M Buy
130,000
+60,000
+86% +$4.94M 0.14% 122
2015
Q2
$6.32M Hold
70,000
0.06% 160
2015
Q1
$7.04M Buy
70,000
+20,000
+40% +$2.02M 0.07% 148
2014
Q4
$5.03M Buy
+50,000
New +$4.98M 0.05% 150
2014
Q3
Sell
-34,100
Closed -$3.18M 403
2014
Q2
$3.18M Buy
+34,100
New +$2.98M 0.02% 227
2013
Q4
Sell
-148,920
Closed -$11.1M 301
2013
Q3
$11.1M Hold
148,920
0.12% 132
2013
Q2
$11.8M Buy
+148,920
New +$11.9M 0.13% 105

Other funds holding MJN

Soros Fund Management's MJN Position: Q2 2017 in Review

Soros Fund Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 205,750 shares — an estimated $18.3M sold.

Soros Fund Management first reported a position in MJN in Q2 2013 and held it in 13 quarters. The position peaked at $18.3M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Soros Fund Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Soros Fund Management sold 205,750 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $18.3M.
  • Soros Fund Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 13 quarters.
  • Soros Fund Management's Mead Johnson Nutrition Company position peaked at $18.3M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Soros Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.